Institutional Ownership Ascendis Pharma A/S (ASND)
This table provides information about the institutional ownership of Ascendis Pharma A/S (ASND). We have compiled data on the 318 institutions that hold shares in the stock, with a total of 65 Million shares, which have been reported (via 13F filing form) to have a value of $13.3 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Ra Capital Management, L.P.
Boston, MA |
Nov 14, 2025 Q3 2025 |
10,281,496
shares
|
$2.1 Billion
35.1% of portfolio
|
Q1 2025
Added 1.67%
|
|
|
Westfield Capital Management CO LP
Boston, MA |
Nov 10, 2025 Q3 2025 |
5,259,909
shares
|
$1.08 Billion
4.77% of portfolio
|
Q3 2025
Reduced 4.0%
|
|
|
Avoro Capital Advisors LLC
New York, NY |
Nov 14, 2025 Q3 2025 |
5,110,000
shares
|
$1.04 Billion
13.88% of portfolio
|
Q3 2025
Added 2.61%
|
|
|
Janus Henderson Group PLC
London, X0 |
Nov 14, 2025 Q3 2025 |
4,323,059
shares
|
$884 Million
0.41% of portfolio
|
Q3 2025
Reduced 2.37%
|
|
|
Lombard Odier Asset Management (Europe) LTD
London, X0 |
Nov 14, 2025 Q3 2025 |
4,269,000
shares
|
$873 Million
0.89% of portfolio
|
Q3 2025
New holding
|
|
|
Artisan Partners Limited Partnership
Milwaukee, WI |
Nov 12, 2025 Q3 2025 |
3,720,880
shares
|
$761 Million
1.13% of portfolio
|
Q3 2025
Reduced 12.59%
|
|
|
Capital International Investors
Los Angeles, CA |
Nov 13, 2025 Q3 2025 |
3,060,616
shares
|
$626 Million
0.1% of portfolio
|
Q3 2025
Added 0.45%
|
|
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
Nov 14, 2025 Q3 2025 |
2,666,618
shares
|
$545 Million
0.32% of portfolio
|
Q3 2025
Reduced 25.59%
|
|
|
Massachusetts Financial Services CO
Boston, MA |
Oct 29, 2025 Q3 2025 |
1,882,781
shares
|
$385 Million
0.12% of portfolio
|
Q3 2025
Reduced 1.0%
|
|
|
Wellington Management Group LLP
Boston, MA |
Nov 14, 2025 Q3 2025 |
1,798,931
shares
|
$368 Million
0.07% of portfolio
|
Q3 2025
Added 95.94%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Nov 14, 2025 Q3 2025 |
1,726,228
shares
|
$353 Million
0.04% of portfolio
|
Q3 2025
Reduced 7.96%
|
|
|
Franklin Resources Inc
San Mateo, CA |
Nov 13, 2025 Q3 2025 |
1,589,956
shares
|
$325 Million
0.08% of portfolio
|
Q3 2025
Reduced 9.33%
|
|
|
Perceptive Advisors LLC
New York, NY |
Nov 14, 2025 Q3 2025 |
1,088,501
shares
|
$222 Million
0.48% of portfolio
|
Q3 2025
Added 12.93%
|
|
|
Invesco Ltd.
Atlanta, GA |
Nov 13, 2025 Q3 2025 |
917,903
shares
|
$188 Million
0.03% of portfolio
|
Q3 2025
Reduced 3.1%
|
|
|
Polar Capital Holdings PLC
London, X0 |
Nov 14, 2025 Q3 2025 |
857,911
shares
|
$175 Million
0.92% of portfolio
|
Q3 2025
Added 2.4%
|
|
|
Principal Financial Group Inc
Des Moines, IA |
Nov 04, 2025 Q3 2025 |
793,677
shares
|
$162 Million
0.09% of portfolio
|
Q3 2025
Added 2722.87%
|
|
|
Putnam Investments LLC
Boston, MA |
Feb 14, 2024 Q4 2023 |
725,651
shares
|
$148 Million
0.13% of portfolio
|
Q4 2023
Reduced 6.05%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2025 Q3 2025 |
653,012
shares
|
$133 Million
0.02% of portfolio
|
Q3 2025
Added 21.31%
|
|
|
Vestal Point Capital, LP
New York, NY |
Nov 14, 2025 Q3 2025 |
600,000
shares
|
$123 Million
5.39% of portfolio
|
Q3 2025
Added 200.0%
|
|
|
Ameriprise Financial Inc
Minneapolis, MN |
Nov 14, 2025 Q3 2025 |
562,936
shares
|
$115 Million
0.03% of portfolio
|
Q3 2025
Reduced 4.27%
|
|
|
American Century Companies Inc
Kansas City, MO |
Nov 12, 2025 Q3 2025 |
544,606
shares
|
$111 Million
0.06% of portfolio
|
Q3 2025
Added 2.6%
|
|
|
Fil LTD
Hamilton, D0 |
Nov 13, 2025 Q3 2025 |
459,340
shares
|
$93.9 Million
0.08% of portfolio
|
Q3 2025
Reduced 1.02%
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2025 Q3 2025 |
406,761
shares
|
$83.1 Million
0.01% of portfolio
|
Q3 2025
Added 59.65%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
405,989
shares
|
$83 Million
0.0% of portfolio
|
Q2 2024
Added 0.2%
|
|
|
Groupama Asset Managment
Paris, I0 |
Dec 01, 2025 Q3 2025 |
400,000
shares
|
$81.8 Million
0.01% of portfolio
|
Q4 2024
Reduced 0.99%
|
|